In the world of markets and money, few things have stood out during the first five months of the year like the dearth of IPOs. While the absence of venture-backed tech IPOs has been the source of most industry consternation, in truth the drought has extended to IPOs of all stripes.
Backed by Clayton, Dubilier & Rice and KKR, US Foods (NYSE: USFD) is one of two major foodservice businesses in the U.S., along with Sysco (NYSE: SYY). The company priced its IPO at $23, on the upper half of its expected range, and has so far been well received by public investors. The company opened trading last week at $24.25, and at end of day Tuesday, its stock was up to $24.99, a 3% climb since open and a 9% increase from its listed IPO price.
Its early success as a public company is not an outlier. Whether it’s a sign that the market is friendlier than most think or that the few companies that have IPO’d are particularly healthy, the vast majority of PE-backed businesses to hit the U.S. markets this year have performed well.
Until US Foods debuted, the most lucrative PE-backed IPO in the U.S. this year was held by Red Rock Resorts (NASDAQ: RRR), which raised $531 million near the end of April. The company’s stock opened at $18.50 and has since climbed to $20.39, a 10% increase.
Armstrong Flooring (NYSE: AFI), the first PE-backed business to IPO in the U.S. this year, has seen its stock climb nearly 30% in two-plus months. BATS Global Markets (BATS: BATS) has undergone a 46% uptick, American Renal Associates (NYSE: ARA) has risen 27% and SiteOne Landscape Supply (NYSE: SITE) has seen a 10% bump.
The other two PE-backed companies that went public last Thursday, Cotiviti (NYSE: COTV) and GMS (NYSE: GMS), have hovered right around their respective IPO share prices during their first days on the markets, with Cotiviti falling 6% and GMS climbing 1.4%.
Making up for lost time
Despite all those promising results, we’re still tracking for the lowest number of PE-backed public offerings in the U.S. since 2008.
Numbers have started to rebound this quarter, but that will have to continue—and then some—to match the full-year totals from 2015 (41) and 2014 (78).Yet with an increasing amount of companies waiting in the IPO pipeline and the calendar just flipping to June, there’s of course lots of time for the trend to turn.
The 1Q slump will be hard to offset in terms of yearly numbers, but there’s plenty of reason right now to believe the PE-backed IPO market will return to a healthier state during the back half of the year.